Cue Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Cue Advisory Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,765	Closed	-$914K	–	41
2018 Q3	$914K	Buy	5,765 +1,438	+33%	+$218K	0.55%	64
2018 Q2	$606K	Buy	4,327 +454	+12%	+$62.3K	0.37%	99
2018 Q1	$515K	Buy	3,873 +1,331	+52%	+$182K	0.34%	107
2017 Q4	$317K	Buy	+2,542	New	+$314K	0.21%	129
2016 Q4	–	Sell	-5,780	Closed	-$576K	–	159
2016 Q3	$576K	Sell	5,780 -199	-3%	-$19.5K	0.49%	80
2016 Q2	$535K	Sell	5,979 -724	-11%	-$66.5K	0.46%	83
2016 Q1	$587K	Sell	6,703 -728	-10%	-$64.1K	0.51%	81
2015 Q4	$840K	Buy	7,431 +3,956	+114%	+$426K	0.75%	52
2015 Q3	$352K	Buy	+3,475	New	+$413K	0.37%	93

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cue Advisory Services's FBT Position: Q4 2018 in Review

Cue Advisory Services sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 5,765 shares — an estimated $914K sold.

Cue Advisory Services first reported a position in FBT in Q3 2015 and held it in 9 quarters. The position peaked at $914K in Q3 2018. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.

Cue Advisory Services reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
Cue Advisory Services sold 5,765 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $914K.
Cue Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2015 and held it in 9 quarters.
Cue Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $914K in Q3 2018.
194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.

Based on Cue Advisory Services's 13F filing for Q4 2018.